FDA Accelerates Approval of Dordaviprone for H3 K27M-Mutant Diffuse Midline Glioma
CompanyDrug

FDA Accelerates Approval of Dordaviprone for H3 K27M-Mutant Diffuse Midline Glioma

Ajinomoto and Amphastar Ink Licensing Pact for Oncology and wAMD Drug Candidates
CompanyDeals

Ajinomoto and Amphastar Ink Licensing Pact for Oncology and wAMD Drug Candidates

Hengrui Pharmaceuticals Gains NMPA Approval for SHR-7782 Clinical Trials in Advanced Solid Tumors
CompanyDrug

Hengrui Pharmaceuticals Gains NMPA Approval for SHR-7782 Clinical Trials in Advanced Solid Tumors

FosunInsightec and Shanghai International Medical Center Establish National Focused Ultrasound Demonstration Center
CompanyDeals

FosunInsightec and Shanghai International Medical Center Establish National Focused Ultrasound Demonstration Center

Minghui Pharmaceutical Secures $131M Pre-IPO Funding Led by OrbiMed and Qiming Ventures
CompanyDeals

Minghui Pharmaceutical Secures $131M Pre-IPO Funding Led by OrbiMed and Qiming Ventures

FDA Approves Precigen's Papzimeos for Recurrent Respiratory Papillomatosis
CompanyDrug

FDA Approves Precigen’s Papzimeos for Recurrent Respiratory Papillomatosis”

Shanghai Pharmaceuticals and Baxter China Forge Strategic Partnership for Anesthesia Products
CompanyDeals

Shanghai Pharmaceuticals and Baxter China Forge Strategic Partnership for Anesthesia Products

CARsgen Therapeutics Reports 2025 Interim Results and Regulatory Progress
Company

CARsgen Therapeutics Reports 2025 Interim Results and Regulatory Progress

Superluminal Collaborates With Eli Lilly on Small Molecule Therapeutics for Cardiometabolic Diseases
CompanyDeals

Superluminal Collaborates With Eli Lilly on Small Molecule Therapeutics for Cardiometabolic Diseases

Sanofi's Rilzabrutinib Granted Orphan Drug Designation for IgG4-Related Disease by EMA
CompanyDrug

Sanofi’s Rilzabrutinib Granted Orphan Drug Designation for IgG4-Related Disease by EMA

China's NHSA Releases Interim Measures for Medical Case-Based Payment Management
Policy / Regulatory

China’s NHSA Releases Interim Measures for Medical Case-Based Payment Management

Pfizer's Emblaveo Prescribed in Shanghai Hospitals for First Time Nationwide
CompanyDrug

Pfizer’s Emblaveo Prescribed in Shanghai Hospitals for First Time Nationwide